The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of survival outcomes in patients with solid organ cancer with brain metastasis treated with exacta encylopedic tumor analysis based treatments.
 
Razelle Kurzrock
Leadership - CureMatch; CureMetrix
Stock and Other Ownership Interests - CureMatch; CureMetrix; IDbyDNA
Honoraria - AACR; Bicara Therapeutics; Biocom; Chugai Pharma USA; EUSA Pharma; Foundation Medicine; LEK; Merck; NeoGenomics Laboratories; NeoMed; Pfizer; Roche; Turning Point Therapeutics; Wiley
Consulting or Advisory Role - Actuate Therapeutics; AstraZeneca; Bicara Therapeutics; Biological Dynamics; Caris Life Sciences; Daiichi Sankyo; Datar Genomics; Eisai; EOM Pharmaceuticals; Gaido; Iylon; LabCorp; Loxo; Merck; NeoGenomics Laboratories; NeoMed; Pfizer; Precirix; Prosperdtx; Regeneron; Roche; Soluventis; TD2/Volastra; Turning Point Therapeutics; XBiotech
Speakers' Bureau - NeoGenomics Laboratories; Roche
Research Funding - Biological Dynamics (Inst); Boehringer Ingelheim (Inst); Debiopharm Group (Inst); Foundation Medicine (Inst); Genentech (Inst); Grifols (Inst); Guardant Health (Inst); Incyte (Inst); Konica Minolta (Inst); MedImmune (Inst); Merck Serono (Inst); NCI (Inst); OmniSeq (Inst); Pfizer (Inst); Sequenom (Inst); Takeda (Inst); Top Alliance BioScience (Inst)
Travel, Accommodations, Expenses - NCI SWOG; TargetCancer Foundation
 
Sewanti Limaye
Employment - Sir H N Reliance Foundation Hospital and Research Centre
Leadership - Iylon; Sir H N Reliance Foundation Hospital and Research Centre
Stock and Other Ownership Interests - Iylon
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche
 
Farzad Massoudi
Leadership - OptumHealth
Stock and Other Ownership Interests - OptumHealth; UnitedHealthcare
Patents, Royalties, Other Intellectual Property - Globus
Travel, Accommodations, Expenses - Steer health
 
Rajan Datar
Leadership - Datar Cancer Genetics
Stock and Other Ownership Interests - Datar Cancer Genetics
 
Ajay Srinivasan
Employment - Datar Cancer Genetics
 
Rahul Ashok Gosavi
Employment - Datar Cancer Genetics
 
Vineet Datta
Employment - Datar Cancer Genetics
Leadership - Datar Cancer Genetics
Stock and Other Ownership Interests - Datar Cancer Genetics
Travel, Accommodations, Expenses - Datar Cancer Genetics
 
Nelofer Syed
No Relationships to Disclose
 
Tim Crook
Stock and Other Ownership Interests - Datar Cancer Genetics